Vimarsana
Biggest News Aggregation in the World

Immunology Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunology Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunology Network Today - Breaking & Trending Today

Neutrophil reprogramming promotes tumor growth in certain cancers - Vimarsana News

Neutrophil reprogramming promotes tumor growth in certain cancers

A new research study led by A*STAR.Singapore Immunology Network (A*STAR.SIgN) has found that neutrophils-;one of the most abundant white blood cells in our body-;change drastically in certain cancers, adopting a new function whereby they promote tumour growth.

How does cancer kill? Scientists trace its deadly steps - Vimarsana News

How does cancer kill? Scientists trace its deadly steps

Neutrophils are a type of white blood cell that serves as the body's first line of defense against infections and inflammation.

Oncofetal ecosystems linked to recurrence and immunotherapy response in liver cancer - Vimarsana News

Oncofetal ecosystems linked to recurrence and immunotherapy response in liver cancer

A team of clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS), Agency for Science, Technology and Research (A*STAR), the Harry Perkins Institute of Medical Research and global research partners, has found a causal link between the presence of oncofetal ecosystems (re-emergence of fetal programme/features driven by the tumor) in the primary liver cancer hepatocellular carcinoma (HCC) and cancer recurrence and response to immunotherapy.

EMBO announces new Global Investigators - Vimarsana News

EMBO announces new Global Investigators

Ten scientists have been selected to join the EMBO Global Investigator Network, an initiative that enables excellent early-stage group leaders based i....

Amphista Therapeutics Expands Senior Team and Announces Appointment of Louise Modis as Chief Scientific Officer and Ian Churcher as Chief Technology Officer - Vimarsana News

Amphista Therapeutics Expands Senior Team and Announces Appointment of Louise Modis as Chief Scientific Officer and Ian Churcher as Chief Technology Officer

/PRNewswire/ -- Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD), today announced that Louise Modis, PhD, has joined the...